Sitryx

Sitryx is a clinical-stage biopharmaceutical company developing novel oral therapies to restore immune balance in inflammatory diseases

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical

Model

01Company Overview

Sitryx is a clinical-stage biopharmaceutical company developing novel oral therapies to restore immune balance in inflammatory diseases. The company focuses on precision immunology and aims to create disease-modifying treatments that go beyond symptom management.

02Backed By1 investor

OSOxford Science Enterprises→

03Similar Companies

Is this your company? Claim your profile